Britannia Life Sciences Inc AI Stock Analysis
Want to see TSE:BLAB full AI Analyst Report?
Britannia Life Sciences Inc (BLAB) AI Stock Analysis
Britannia Life Sciences Inc
(CNQX:BLAB)
TSE:BLAB's overall score is significantly weighed down by a struggling core business and a prevailing technical downtrend. While the company boasts a pristine, debt-free balance sheet, plummeting revenues, persistent cash burn, and a reliance on non-operating gains to drive net income make it a high-risk proposition. The superficially cheap valuation reflects this operational instability rather than a true bargain.
Britannia Life Sciences Inc (BLAB) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 11.36M
- Dividend Yield
- ―
- Average Volume (3M)
- 52.12K
- Price to Earnings (P/E)
- 0.8
- Beta (1Y)
- -1.62
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Canada
- Employees
- 28
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
Britannia Life Sciences Inc Business Overview & Revenue Model
Company Description
Britannia Life Sciences Inc., headquartered in Toronto, Canada, offers specialized services in rigorous product evaluation, comprehensive safety analysis, and adherence to regulatory standards. The company supports businesses within the cosmetics, nu...
Britannia Life Sciences Inc Financial Statement Overview
Summary
Despite an exceptional balance sheet with virtually zero debt, severe revenue deterioration, negative operating margins, and ongoing cash burn indicate critical weakness in the core business.
Income Statement
30NegativeBalance Sheet
90Very PositiveCash Flow
30Negative| Breakdown | TTM | Jun 2025 | Mar 2025 | Jun 2023 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 406.44K | 474.83K | 369.28K | 7.57M | 6.40M | 7.30M |
| Gross Profit | 30.00K | 38.86K | 27.33K | 4.85M | 4.64M | 5.26M |
| EBITDA | -1.07M | -1.39M | -4.39M | -1.90M | 6.95M | -10.77M |
| Net Income | 16.54M | 13.07M | 7.39M | -4.77M | 5.08M | -15.46M |
Balance Sheet | ||||||
| Total Assets | 24.84M | 23.87M | 11.61M | 22.26M | 23.55M | 21.09M |
| Cash, Cash Equivalents and Short-Term Investments | 12.41M | 17.14M | 7.85M | 1.32M | 2.60M | 1.63M |
| Total Debt | 211.52K | 229.14K | 1.86M | 7.29M | 8.41M | 5.19M |
| Total Liabilities | 2.79M | 3.12M | 5.31M | 15.59M | 12.49M | 15.61M |
| Stockholders Equity | 22.05M | 20.75M | 6.30M | 2.44M | 7.02M | 1.35M |
Cash Flow | ||||||
| Free Cash Flow | -665.64K | -1.16M | -2.62M | 1.75M | 874.41K | 2.71M |
| Operating Cash Flow | -665.65K | -1.16M | -2.62M | 2.09M | 1.22M | 2.80M |
| Investing Cash Flow | 6.04M | -5.25M | 11.27M | -1.44M | -3.32M | 653.95K |
| Financing Cash Flow | 34.44K | -110.77K | -2.17M | -1.97M | 2.95M | -2.58M |
Britannia Life Sciences Inc Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BLAB, the sentiment is Positive. The current price of 0.07 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.07, and below the 200-day MA of 0.08, indicating a neutral trend. The MACD of 0.00 indicates Positive momentum. The RSI at 72.92 is Negative, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:BLAB.
Britannia Life Sciences Inc Peers Comparison
Overall Rating
TSE:GLOW56Neutral
TSE:BLAB51Neutral
TSE:TELI41Neutral
TSE:HEM40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 56Neutral | CAD 6.74M | -43.75 | -10.61% | ― | 56.41% | 91.30% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | CAD 11.36M | 0.76 | 101.66% | ― | ― | ― | |
| 41Neutral | CAD 20.20M | 4.68 | 114.66% | ― | 94.58% | ― | |
| 40Underperform | CAD 7.40M | -1.42 | 92.37% | ― | ― | 16.04% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:BLAB | Britannia Life Sciences Inc | 0.07 | -0.02 | -22.22% | |
| TSE:HEM | Hemostemix Inc | 0.04 | -0.04 | -56.25% | |
| TSE:IOT | Innovotech Inc | 0.07 | -0.17 | -70.83% | |
| TSE:GLOW | Glow Lifetech Corp | 0.04 | -0.01 | -30.00% | |
| TSE:TELI | Telescope Innovations Corp | 0.25 | -0.13 | -34.21% |
Britannia Life Sciences Inc Corporate Events
Britannia Life Sciences Launches Share Buyback to Boost Long-Term Value
PositiveBritannia Life Sciences Inc. has launched a normal course issuer bid that will allow the company to repurchase and cancel up to 8,112,717 common shares, representing 5% of its issued and outstanding stock, over a 12‑month period starting August 10, 2...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 26, 2026
